Reviews Buminate 5%


No reviews yet.

Buminate 5% Drug Description
BUMINATE 5%
Albumin (Human), USP, 5% Solution

This bottle contains 12.5 g albumin from venous plasma in saline and is osmotically equivalent to an equal volume of normal human plasma. It has been stabilized with sodium caprylate and sodium acetyltryptophanate and heated for 10 hours at 60°C. The sodium content is 145 ±15 mEq/L. Contains no preservative. Store at room temperature, not to exceed 30°C (86°F). Avoid freezing to prevent damage to the bottle. See attached directions for use.
Do not use if turbid. Do not begin administration more than 4 hours after
the container has been entered. Single dose container. Discard partially
used bottle.
The patient and physician should discuss the risks and benefits of this product.

DRUG DESCRIPTION
BUMINATE 5%, Albumin (Human), 5% Solution is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. Each 100 mL contains 5 g of albumin and is prepared from human venous plasma using the Cohn cold ethanol fractionation process. Source material for fractionation may be obtained from another U.S. licensed manufacturer. It has been adjusted to physiological pH with sodium bicarbonate and/or sodium hydroxide and has been stabilized with sodium acetyltryptophanate and sodium caprylate. The sodium content is 145 ±15 mEq/L. The solution contains no preservative and none of the coagulation factors found in fresh whole blood or plasma. BUMINATE 5%, Albumin (Human), 5% Solution is a transparent or slightly opalescent solution which may have a greenish tint or may vary from a pale straw to an amber color.
The likelihood of the presence of viable hepatitis viruses has been reduced
by heating the product for 10 hours at 60°C. This procedure has been shown
to be an effective method of inactivating hepatitis virus in albumin solutions
even when those solutions were prepared from plasma known to be infective.1-3
BUMINATE 5%, Albumin (Human), 5% Solution contains no blood group isoagglutinins thereby permitting its administration without regard to the recipient's blood group.
References
1. Gellis SS, Neefe JR, Stokes J Jr, et al: Chemical, clinical and immunological
studies on the products of human plasma fractionation. XXXVI. Inactivation of
the virus of homologous serum hepatitis in solutions of normal human serum albumin
by means of heat. J Clin Invest 27:239-244, 1948
2. Gerety RJ, Aronson DL: Plasma derivatives and viral hepatitis. Transfusion 22:347-351, 1982
3. Murray R, Diefenbach WCL, Geller H, etat Problem of reducing danger of serum hepatitis from blood and blood products. NY State J Med 55:1145-1150, 1955
Last reviewed on RxList: 1/21/2009




Buminate 5% Drug Description
BUMINATE 5%
Albumin (Human), USP, 5% Solution

This bottle contains 12.5 g albumin from venous plasma in saline and is osmotically equivalent to an equal volume of normal human plasma. It has been stabilized with sodium caprylate and sodium acetyltryptophanate and heated for 10 hours at 60°C. The sodium content is 145 ±15 mEq/L. Contains no preservative. Store at room temperature, not to exceed 30°C (86°F). Avoid freezing to prevent damage to the bottle. See attached directions for use.
Do not use if turbid. Do not begin administration more than 4 hours after
the container has been entered. Single dose container. Discard partially
used bottle.
The patient and physician should discuss the risks and benefits of this product.

DRUG DESCRIPTION
BUMINATE 5%, Albumin (Human), 5% Solution is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. Each 100 mL contains 5 g of albumin and is prepared from human venous plasma using the Cohn cold ethanol fractionation process. Source material for fractionation may be obtained from another U.S. licensed manufacturer. It has been adjusted to physiological pH with sodium bicarbonate and/or sodium hydroxide and has been stabilized with sodium acetyltryptophanate and sodium caprylate. The sodium content is 145 ±15 mEq/L. The solution contains no preservative and none of the coagulation factors found in fresh whole blood or plasma. BUMINATE 5%, Albumin (Human), 5% Solution is a transparent or slightly opalescent solution which may have a greenish tint or may vary from a pale straw to an amber color.
The likelihood of the presence of viable hepatitis viruses has been reduced
by heating the product for 10 hours at 60°C. This procedure has been shown
to be an effective method of inactivating hepatitis virus in albumin solutions
even when those solutions were prepared from plasma known to be infective.1-3
BUMINATE 5%, Albumin (Human), 5% Solution contains no blood group isoagglutinins thereby permitting its administration without regard to the recipient's blood group.
References
1. Gellis SS, Neefe JR, Stokes J Jr, et al: Chemical, clinical and immunological
studies on the products of human plasma fractionation. XXXVI. Inactivation of
the virus of homologous serum hepatitis in solutions of normal human serum albumin
by means of heat. J Clin Invest 27:239-244, 1948
2. Gerety RJ, Aronson DL: Plasma derivatives and viral hepatitis. Transfusion 22:347-351, 1982
3. Murray R, Diefenbach WCL, Geller H, etat Problem of reducing danger of serum hepatitis from blood and blood products. NY State J Med 55:1145-1150, 1955
Last reviewed on RxList: 1/21/2009




Buminate 5% Drug Description
BUMINATE 5%
Albumin (Human), USP, 5% Solution

This bottle contains 12.5 g albumin from venous plasma in saline and is osmotically equivalent to an equal volume of normal human plasma. It has been stabilized with sodium caprylate and sodium acetyltryptophanate and heated for 10 hours at 60°C. The sodium content is 145 ±15 mEq/L. Contains no preservative. Store at room temperature, not to exceed 30°C (86°F). Avoid freezing to prevent damage to the bottle. See attached directions for use.
Do not use if turbid. Do not begin administration more than 4 hours after
the container has been entered. Single dose container. Discard partially
used bottle.
The patient and physician should discuss the risks and benefits of this product.

DRUG DESCRIPTION
BUMINATE 5%, Albumin (Human), 5% Solution is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. Each 100 mL contains 5 g of albumin and is prepared from human venous plasma using the Cohn cold ethanol fractionation process. Source material for fractionation may be obtained from another U.S. licensed manufacturer. It has been adjusted to physiological pH with sodium bicarbonate and/or sodium hydroxide and has been stabilized with sodium acetyltryptophanate and sodium caprylate. The sodium content is 145 ±15 mEq/L. The solution contains no preservative and none of the coagulation factors found in fresh whole blood or plasma. BUMINATE 5%, Albumin (Human), 5% Solution is a transparent or slightly opalescent solution which may have a greenish tint or may vary from a pale straw to an amber color.
The likelihood of the presence of viable hepatitis viruses has been reduced
by heating the product for 10 hours at 60°C. This procedure has been shown
to be an effective method of inactivating hepatitis virus in albumin solutions
even when those solutions were prepared from plasma known to be infective.1-3
BUMINATE 5%, Albumin (Human), 5% Solution contains no blood group isoagglutinins thereby permitting its administration without regard to the recipient's blood group.
References
1. Gellis SS, Neefe JR, Stokes J Jr, et al: Chemical, clinical and immunological
studies on the products of human plasma fractionation. XXXVI. Inactivation of
the virus of homologous serum hepatitis in solutions of normal human serum albumin
by means of heat. J Clin Invest 27:239-244, 1948
2. Gerety RJ, Aronson DL: Plasma derivatives and viral hepatitis. Transfusion 22:347-351, 1982
3. Murray R, Diefenbach WCL, Geller H, etat Problem of reducing danger of serum hepatitis from blood and blood products. NY State J Med 55:1145-1150, 1955
Last reviewed on RxList: 1/21/2009




Buminate 5% Drug Description
BUMINATE 5%
Albumin (Human), USP, 5% Solution

This bottle contains 12.5 g albumin from venous plasma in saline and is osmotically equivalent to an equal volume of normal human plasma. It has been stabilized with sodium caprylate and sodium acetyltryptophanate and heated for 10 hours at 60°C. The sodium content is 145 ±15 mEq/L. Contains no preservative. Store at room temperature, not to exceed 30°C (86°F). Avoid freezing to prevent damage to the bottle. See attached directions for use.
Do not use if turbid. Do not begin administration more than 4 hours after
the container has been entered. Single dose container. Discard partially
used bottle.
The patient and physician should discuss the risks and benefits of this product.

DRUG DESCRIPTION
BUMINATE 5%, Albumin (Human), 5% Solution is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. Each 100 mL contains 5 g of albumin and is prepared from human venous plasma using the Cohn cold ethanol fractionation process. Source material for fractionation may be obtained from another U.S. licensed manufacturer. It has been adjusted to physiological pH with sodium bicarbonate and/or sodium hydroxide and has been stabilized with sodium acetyltryptophanate and sodium caprylate. The sodium content is 145 ±15 mEq/L. The solution contains no preservative and none of the coagulation factors found in fresh whole blood or plasma. BUMINATE 5%, Albumin (Human), 5% Solution is a transparent or slightly opalescent solution which may have a greenish tint or may vary from a pale straw to an amber color.
The likelihood of the presence of viable hepatitis viruses has been reduced
by heating the product for 10 hours at 60°C. This procedure has been shown
to be an effective method of inactivating hepatitis virus in albumin solutions
even when those solutions were prepared from plasma known to be infective.1-3
BUMINATE 5%, Albumin (Human), 5% Solution contains no blood group isoagglutinins thereby permitting its administration without regard to the recipient's blood group.
References
1. Gellis SS, Neefe JR, Stokes J Jr, et al: Chemical, clinical and immunological
studies on the products of human plasma fractionation. XXXVI. Inactivation of
the virus of homologous serum hepatitis in solutions of normal human serum albumin
by means of heat. J Clin Invest 27:239-244, 1948
2. Gerety RJ, Aronson DL: Plasma derivatives and viral hepatitis. Transfusion 22:347-351, 1982
3. Murray R, Diefenbach WCL, Geller H, etat Problem of reducing danger of serum hepatitis from blood and blood products. NY State J Med 55:1145-1150, 1955
Last reviewed on RxList: 1/21/2009




Buminate 5% Drug Description
BUMINATE 5%
Albumin (Human), USP, 5% Solution

This bottle contains 12.5 g albumin from venous plasma in saline and is osmotically equivalent to an equal volume of normal human plasma. It has been stabilized with sodium caprylate and sodium acetyltryptophanate and heated for 10 hours at 60°C. The sodium content is 145 ±15 mEq/L. Contains no preservative. Store at room temperature, not to exceed 30°C (86°F). Avoid freezing to prevent damage to the bottle. See attached directions for use.
Do not use if turbid. Do not begin administration more than 4 hours after
the container has been entered. Single dose container. Discard partially
used bottle.
The patient and physician should discuss the risks and benefits of this product.

DRUG DESCRIPTION
BUMINATE 5%, Albumin (Human), 5% Solution is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. Each 100 mL contains 5 g of albumin and is prepared from human venous plasma using the Cohn cold ethanol fractionation process. Source material for fractionation may be obtained from another U.S. licensed manufacturer. It has been adjusted to physiological pH with sodium bicarbonate and/or sodium hydroxide and has been stabilized with sodium acetyltryptophanate and sodium caprylate. The sodium content is 145 ±15 mEq/L. The solution contains no preservative and none of the coagulation factors found in fresh whole blood or plasma. BUMINATE 5%, Albumin (Human), 5% Solution is a transparent or slightly opalescent solution which may have a greenish tint or may vary from a pale straw to an amber color.
The likelihood of the presence of viable hepatitis viruses has been reduced
by heating the product for 10 hours at 60°C. This procedure has been shown
to be an effective method of inactivating hepatitis virus in albumin solutions
even when those solutions were prepared from plasma known to be infective.1-3
BUMINATE 5%, Albumin (Human), 5% Solution contains no blood group isoagglutinins thereby permitting its administration without regard to the recipient's blood group.
References
1. Gellis SS, Neefe JR, Stokes J Jr, et al: Chemical, clinical and immunological
studies on the products of human plasma fractionation. XXXVI. Inactivation of
the virus of homologous serum hepatitis in solutions of normal human serum albumin
by means of heat. J Clin Invest 27:239-244, 1948
2. Gerety RJ, Aronson DL: Plasma derivatives and viral hepatitis. Transfusion 22:347-351, 1982
3. Murray R, Diefenbach WCL, Geller H, etat Problem of reducing danger of serum hepatitis from blood and blood products. NY State J Med 55:1145-1150, 1955
Last reviewed on RxList: 1/21/2009





Other reviews about Buminate 5% on wordpress

Health Information from Natural Solutions Radio -- Pandemic Flu Alert: Media Reports Virus Vaccine Contamination
  by rasticus
Pandemic Flu Alert: Media Reports Virus Vaccine Contamination Big Pharma Company “Accidentally” Contaminates Vaccines with AVIAN FLU VIRUS April 08, 2009 Number of Times Visited: 81 Category: General Health Natural […]


Health Information from Natural Solutions Radio -- Pandemic Flu Alert: Media Reports Virus Vaccine Contamination
  by rasticus
Pandemic Flu Alert: Media Reports Virus Vaccine Contamination Big Pharma Company “Accidentally” Contaminates Vaccines with AVIAN FLU VIRUS April 08, 2009 Number of Times Visited: 81 Category: General Health Natural […]


Bioweapons, Dangerous Vaccines, and Threats of a Global Pandemic
  by honeymanrp
By Stephen Lendman (The Intelligence Daily) -- Although international law prohibits the use of chemical and bacteriological weapons, America has had an active biological warfare program since at least […]


Bioweapons, Dangerous Vaccines, and Threats of a Global Pandemic
  by mosesman
The Illuminati's depopulation agenda is very much alive. 3 methods of mass culling of sheeple will be activated: war, famine and disease. Sounds familiar? Jesus Christ said in Matthew […]


Bioweapons, Dangerous Vaccines, and Threats of a Global Pandemic
  by afteramerica
by Stephen Lendman [caption id="attachment_563" align="alignnone" width="357" caption="Eugenics, killing you to protect Big Pharma Profits!"][/caption] Although international law prohibits the use of chemical and bacteriological weapons, America has had an […]


Bioweapons, Dangerous Vaccines, and Threats of a Global Pandemic
  by pjwalker911
Global Research | Jul 8, 2009 by Stephen Lendman   Although international law prohibits the use of chemical and bacteriological weapons, America has had an active biological warfare program since at […]


Introduction: The Many Faces of Eugenics
  by Pi
Eugenics is the study of, or belief in, the possibility of improving the qualities of the human species or a human population by such means as discouraging reproduction […]


Baxter “Accidentally” Contaminates Vaccines With LIVE AVIAN FLU VIRUS in 18 Countries
  by CosmicMind
http://www.healthfreedomusa.org/?p=2220 The General’s Communiqué Maj. Gen. Albert N. Stubblebine III (US Army, Ret.) Big Pharma Company “Accidentally” Contaminates Vaccines With LIVE AVIAN FLU VIRUS in 18 Countries Dr. Rima and I are still in Germany […]


Stephen Lendman: Bioweapons, Dangerous Vaccines, and Threats of a Global Pandemic
  by Steve Beckow
by Stephen Lendman Undated. http://eugenicsagenda.wordpress.com/category/submitted-to-the-court-of-public-opinion/uncategorized/ Although international law prohibits the use of chemical and bacteriological weapons, America has had an active biological warfare program since at least the 1940s. In 1941, […]



Other reviews about Buminate 5% on web:

Learn about the prescription medication Buminate 5% (Albumin (Human) 5% Solution), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Buminate 5% (Albumin (Human) 5% Solution) Drug Information: Uses ...


BUMINATE 5%, Albumin (Human), USP, 5% Solution DESCRIPTION BUMINATE 5%, in 250 and 500 mL glass bottles is a sterile, nonpyrogenic preparation of albumin in a single dosage form for ... BUMINATE 5%, Albumin (Human), USP, 5% Solution


BUMINATE 5% SUMMARY BUMINATE 5%, Albumin (Human), 5% Solution, is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. Buminate 5% (Albumin) - Drug Info, Side Effects, Research ...


BUMINATE 5% Albumin (Human), USP, 5% Solution Description BUMINATE 5%, Albumin (Human), 5% Solution, is a sterile, nonpyrogenic preparation of albumin in a single dosage form for ... BUMINATE 5% Albumin (Human), USP, 5% Solution


Buminate 5% Solution, USP (Baxter Healthcare), Drug Reference Encyclopedia - Physicians PDR Buminate 5% Solution, USP (Baxter Healthcare), Drug Reference ...


BUMINATE is high-quality albumin packaged in glass bottles. ... BUMINATE [Albumin (Human)], 5% and 25% Solutions. Baxter also offers the same high-quality human albumin packaged in ... AlbuminTherapy.com | Albumin Therapy Products | BUMINATE


DESCRIPTION. BUMINATE 5%, Albumin (Human), 5% Solution, is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. Buminate 5% (Albumin) - Description and Clinical Pharmacology


Buminate 5% Drug Information from Drugs.com. Includes Buminate 5% side effects, interactions and indications. Buminate 5% Drug Information, Professional


Instructions for using the BUMINATE 5%, Albumin (Human), USP, 5% Solution 250 mL booklet sling label Based on user feedback, Baxter is modifying the hanging device on the BUMINATE 5% ... Instructions for using the BUMINATE 5%, Albumin (Human), USP, 5% ...


Find patient medical information for Buminate 5 % IV on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Buminate 5 % IV : Uses, Side Effects, Interactions, Pictures ...





Featured Reviews

Reviews Amoxapine Tablets

Amoxapine Drug Description AMOXAPINE (amoxapine) Tablets USP Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents,...
Read More  |  Review This
Reviews Bontril

Bontril Drug Description BONTRIL® (phendimetrazine tartrate) Tablets, USP 35 mg DRUG DESCRIPTION What are the possible side effects of phendimetrazine? If you experience any of the following serious side effects, stop taking...
Read More  |  Review This
Reviews Dovonex Cream

Dovonex Cream Drug Description Dovonex® (calcipotriene cream) Cream, 0.005% FOR TOPICAL DERMATOLOGIC USE ONLY. Not for Ophthalmic, Oral or Intravaginal Use. DRUG DESCRIPTION What are the possible side effects of calcipotriene...
Read More  |  Review This
Reviews Benadryl

Benadryl Drug Description BENADRYL® Allergy (diphenhydramine) DRUG DESCRIPTION What are the possible side effects of diphenhydramine? Stop taking diphenhydramine and seek emergency medical attention if you experience an allergic...
Read More  |  Review This
Reviews Itraconazole Injection

Sporanox Injection Drug Description SPORANOX® (itraconazole) Injection Congestive Heart Failure: When itraconazole was administered intravenously to dogs and healthy human volunteers, negative inotropic effects were seen....
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....